
|Articles|May 12, 2023
Pharma 2023: Vaccines Journey to the Consumer
Stefan Merlo, Vice President, Commercial Development, CSL Seqirus discusses how COVID-19 has evolved the discussion of vaccines and the long-term concerns stemming from flu vaccine fatigue.
Advertisement
At Pharma 2023 in Barcelona, Stefan Merlo, Vice President, Commercial Development at CSL Seqirus, discussed the global vaccine journey, the connected customer experience and the role of consumer and government education to improve public health.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
2
JP Morgan 2026: AbbVie Advances its Pipeline
3
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference?
4
Novartis Calls for Global Governments to Address Global Trade Policy
5




